We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Report 2019

In this report, the Asia-Pacific Opioid Induced Constipation (OIC) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers/players, with Opioid Induced Constipation (OIC) Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
By Drug Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
By Prescription Type
Generic and Branded Prescribed Drugs
Over The Counter Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for each application, includin
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Report 2017
1 Opioid Induced Constipation (OIC) Drugs Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Classification of Opioid Induced Constipation (OIC) Drugs by Product Category
1.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Lubiprostone
1.2.4 Methyl Naltrexone Bromide
1.2.5 Naldemedine
1.2.6 Alvimopan
1.2.7 Other
1.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market by Application/End Users
1.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market by Region
1.4.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Opioid Induced Constipation (OIC) Drugs (2012-2022)
1.5.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs (Volume and Value) by Type
2.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs (Volume) by Application
2.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs (Volume and Value) by Region
2.4.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Region (2012-2017)

3 China Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
3.1 China Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
3.1.1 China Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 China Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
3.1.3 China Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
3.2 China Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
3.3 China Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

4 Japan Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
4.1 Japan Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
4.1.1 Japan Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
4.1.3 Japan Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
4.2 Japan Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
4.3 Japan Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

5 South Korea Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
5.1 South Korea Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
5.1.1 South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
5.2 South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
5.3 South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

6 Taiwan Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
6.1 Taiwan Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
6.1.1 Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
6.3 Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

7 India Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
7.1 India Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
7.1.1 India Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
7.1.2 India Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
7.1.3 India Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
7.2 India Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
7.3 India Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

8 Southeast Asia Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
8.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
8.1.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

9 Australia Opioid Induced Constipation (OIC) Drugs (Volume, Value and Sales Price)
9.1 Australia Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
9.1.1 Australia Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
9.1.3 Australia Opioid Induced Constipation (OIC) Drugs Sales Price Trend (2012-2017)
9.2 Australia Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Type
9.3 Australia Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Players/Suppliers Profiles and Sales Data
10.1 Ironwood Pharmaceuticals Inc
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Daiichi Sankyo Co Ltd
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Pfizer
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Progenics Pharmaceuticals Inc
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Shionogi & Co., Ltd
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Allergan Plc
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Nektar Therapeutics
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Purdue Pharma
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 S.L.A. Pharma AG
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Mundipharma International Limited
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Ono Pharmaceutical Co., Ltd
10.12 Takeda Pharmaceutical Company Limited
10.13 Theravance Biopharma Inc
10.14 Valeant Pharmaceuticals International
10.15 Cosmo Pharmaceuticals SA
10.16 Daewoong Pharmaceutical
10.17 C.B. Fleet Company
10.18 Sucampo Pharmaceuticals

11 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
11.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Forecast (2017-2022)
15.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Lubiprostone Product Picture
Figure Methyl Naltrexone Bromide Product Picture
Figure Naldemedine Product Picture
Figure Alvimopan Product Picture
Figure Other Product Picture
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share by Players
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2012-2017)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2012-2017)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Region (2012-2017)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Region (2012-2017)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2012-2017)
Figure China Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table China Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table China Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table Japan Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Figure India Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table India Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Figure Australia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2016
Table Australia Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Application in 2016
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Basic Information List
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Basic Information List
Table C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2016
Table Major Buyers of Opioid Induced Constipation (OIC) Drugs
Table Distributors/Traders List
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Region in 2022
Figure China Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved